International Business News - MRX http://www.ibtimes.com All articles are copyrighted by IBTimes.com 400 100 http://www.ibtimes.com/ http://www.ibtimes.com/images/top_logo_ibt2_3.gif Medical device companies are developing targeted, nonsurgical ways to remove fat from a patient's body, a trend Medicis Pharmaceutical Corp. may be banking on in its purchase of LipoSonix. http://www.ibtimes.com/articles/20080617/fat-treatment-market-expands-to-ultrasound-lasers.htm Tue, 17 Jun 2008 15:47:30 EDT Medicis Pharmaceutical Corp. said Monday it will by privately held LipoSonix for $150 million in cash in a move to expand its aesthetics portfolio. Medicis makes a range of specialty pharmaceutical products to treat acne and skin conditions along with cosmetic dermal fillers. LipoSonix makes a system that uses ultrasound technology to remove unwanted fat. The product is not yet approved in the U.S., though Medicis expects it could enter the market by 2011. http://www.ibtimes.com/articles/20080616/medicis-buying-liposonix-for-150-million.htm Mon, 16 Jun 2008 16:36:47 EDT Medicis Pharmaceutical Corp. said Wednesday its board declared a regular quarterly dividend of 4 cents. The pharmaceutical company said the dividend is payable July 31 to shareholders of record July 1. http://www.ibtimes.com/articles/20080612/medicis-declares-regular-dividend-of-4-cents.htm Thu, 12 Jun 2008 17:25:10 EDT Among the earnings stories for Thursday, May 8, from AP Financial News: CHELMSFORD, Mass. (AP) _ Brooks Automation Inc. said Thursday it swung to fiscal second-quarter loss as revenue fell sharply amid a corporate restructuring. http://www.ibtimes.com/articles/20080508/earnings-roundup-brooks-automation-verisign.htm Thu, 08 May 2008 19:13:55 EDT Medicis Pharmaceutical Corp. raised its full-year profit guidance Thursday after its first-quarter results topped expectations. The company expects 2008 profit between $1.49 and $1.58 per share on revenue between $529 million and $538 million. In February, the company set full-year profit guidance between $1.43 and $1.56 per share on revenue between $528 million and $540 million. Analysts on average expect a profit of $1.51 per share on revenue $534.4 million. http://www.ibtimes.com/articles/20080508/medicis-pharmaceutical-raises-full-year-profit-outlook.htm Thu, 08 May 2008 16:52:06 EDT Medicis on Wednesday said its board raised its quarterly dividend by a penny, or 33 percent, to 4 cents per share. The pharmaceutical company said the dividend is payable April 30 to shareholders of record April 1. http://www.ibtimes.com/articles/20080313/medicis-lifts-quarterly-dividend.htm Thu, 13 Mar 2008 10:35:39 EDT Medicis Pharmaceutical Corp. said Wednesday its fourth-quarter profit jumped 54 percent on higher sales of the company's acne treatment products. The company earned $27.5 million, or 41 cents per share, compared with profit of $17.9 million, or 27 cents per share, during the same period a year prior. Revenue rose 42 percent to $140.3 million from $99.1 million. http://www.ibtimes.com/articles/20080227/medicis-4q-profit-rises-on-acne-products.htm Wed, 27 Feb 2008 18:24:53 EST Among the stock activity stories for Thursday, Jan. 31, from AP Financial News: NEW YORK (AP) _ Shares of home medical equipment company Invacare Corp. jumped Thursday after the company topped Wall Street's fourth-quarter expectations on a mix of lower costs and higher rehabilitation product sales. http://www.ibtimes.com/articles/20080131/movers-roundup-invacare-harris-stratex.htm Thu, 31 Jan 2008 18:17:11 EST Shares of Botox and breast implant maker Allergan Inc. got a boost Thursday after the Food and Drug Administration denied Medicis Pharmaceutical Corp.'s application for rival wrinkle product Reloxin. http://www.ibtimes.com/articles/20080131/allergan-up-as-fda-stumps-rival-medicis.htm Thu, 31 Jan 2008 14:48:47 EST Medicis Pharmaceutical Corp. said Thursday the Food and Drug Administration has denied its application for wrinkle injection Reloxin, botulinum toxin type A, because it isn't "sufficiently complete." http://www.ibtimes.com/articles/20080131/fda-denies-incomplete-medicis-filing.htm Thu, 31 Jan 2008 09:46:55 EST Allergan Inc. could kick off a positive round of quarterly earnings reports Wednesday, despite concerns that a weakening economy has weighed down sales of products including Botox and breast implants. http://www.ibtimes.com/articles/20080128/sector-snap-aesthetic-product-makers.htm Mon, 28 Jan 2008 11:38:38 EST Shares of Medicis Pharmaceutical Corp., which makes skin medications, fell sharply to a new annual low after Impax Laboratories challenged a patent for its Solodyn drug for the treatment of acne. http://www.ibtimes.com/articles/20080115/medicis-key-drug-faces-patent-challenge.htm Tue, 15 Jan 2008 19:36:34 EST Taking a page from the MTV concert series, the investment bank Morgan Stanley hosts the chief executives of the largest pharmaceutical companies on Thursday and Friday for a conference series it calls "Unplugged." http://www.ibtimes.com/articles/20080103/ahead-of-the-bell-pharma-conference.htm Thu, 03 Jan 2008 07:06:00 EST